September 23rd, 2013
HDL-P: The Better Marker of Residual Risk?
Samia Mora, MD, MHS
CardioExchange Editors interview Samia Mora about her investigative group’s analysis of data from the JUPITER trial, which reveals that HDL-P may be a better marker of residual risk than chemically measured HDL-C or apoA-1.
September 23rd, 2013
Selections from Richard Lehman’s Literature Review: September 23rd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include a randomized trial of preventive angioplasty in MI, aliskiren in patients with prehypertension, and otamixaban and ischemic events in NSTE-ACS.
September 22nd, 2013
Join a Conversation About Health Care Innovation
CardioExchange Editors, Staff
Join the conversation launched by The New England Journal of Medicine and Harvard Business Review about the future of health care innovation.
September 20th, 2013
Taking a Clear-Eyed View of Statins and Cataracts
Larry Husten, PHD
Past observational studies have turned up conflicting findings about the effects, if any, of statins on developing cataracts. Now a large new observational study finds a small but significant increase in cataracts in statin users, however, experts warn that without further support the new finding should probably not influence clinical practice. In a paper published […]
September 20th, 2013
My Stent Is Better Than Your Stent
Richard A. Lange, MD, MBA and L. David Hillis, MD
Interventionalists have many choices when it comes to coronary stents. Rick Lange and David Hillis want to know: “How do you decide which stent to use?”
September 19th, 2013
Clopidogrel’s Benefits Seen Mainly in Smokers
Nicholas Downing, MD
Clopidogrel appears to offer more protection against cardiovascular events among smokers than nonsmokers, according to a systematic review in BMJ. Researchers examined data from six randomized trials comparing clopidogrel (alone or with aspirin) with control treatments (namely, aspirin alone or lower-dose clopidogrel plus aspirin). Nearly 75,000 patients with established cardiovascular disease, 30% of whom were […]
September 19th, 2013
A Novel Navigation System for CRT Device Implantation
Sergio Richter, MD
Sergio Richter discusses his research group’s study of a non–fluoroscopy-based tracking system that can be used when implanting a CRT device.
September 18th, 2013
Disparities in Rate of Inappropriate Use of PCI
Paul S. Chan, MD, MS
Paul Chan answers questions about his new study in JACC that found a surprising pattern of both overuse and underuse of PCI among different populations in the US.
September 18th, 2013
Both Overuse and Underuse Explain Disparities in Coronary Revascularization
Larry Husten, PHD
A new study finds that groups who have often been found to receive less medical care — non-whites, women, and people without private insurance or who are from urban and rural areas — are less likely to undergo coronary revascularization. But the same study finds that this disparity may be in no small part due to […]
September 18th, 2013
Younger Women with ACS Less Likely to Have Chest Pain
Larry Husten, PHD
Younger women with an acute coronary syndrome are slightly less likely than men to present with the classic symptom of chest pain, according to a new study published in JAMA Internal Medicine. In recent years there has been a growing understanding that women with ACS are less likely to have chest pain and, partly as a result, […]